Escalating Burden of Osteoarthritis Among Asian Women: Regional Trends, BMI-Attributable Disability, and Projections to 2050
- 1Department of Traumatology and Joint Surgery, The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, Guangdong, People’s Republic of China
Abstract
Background: Osteoarthritis (OA) imposes a substantial and growing burden on women in Asia, yet comprehensive sex-specific and subregional analyses that incorporate causal inference and long-term forecasting remain limited.
Objective: This study quantified the burden of OA among Asian women from 1990 to 2023, characterized spatiotemporal patterns, projected trends to 2050, and evaluated the causal role of high body mass index (BMI).
Methods: Using Global Burden of Disease 2023 data, we extracted age-standardized incidence (ASIR), prevalence, and disability-adjusted life-year rates for women across Asian regions and countries. Temporal trends were assessed with estimated annual percentage change and joinpoint regression. Future burden was forecasted using Bayesian age-period-cohort (BAPC) models and exponential smoothing (ETS) models. The proportion of OA disability attributable to high BMI was calculated. Two-sample Mendelian randomization (MR) used sex-combined East Asian BMI and mixed-ancestry OA genome-wide association study (GWAS) data.
Results: In 2023, female ASIR was highest in East Asia (658.85 per 100,000) and Central Asia (613.07 per 100,000), while other Asian subregions were below the global female ASIR. Age-specific incidence peaked at 50–59 age group across all sub-regions. Asian regions showed faster long-term increases than the global average, although most exhibited deceleration after 2020. Projections indicate that by 2050, the ASIR of OA in females will decline across all regions. The high BMI attributable fraction of OA disability rose markedly, reaching 29.0% in Western Asia. The reported multiplicative random-effects inverse-variance-weighted (IVW) MR estimate was an odds ratio (OR) of 1.21 (95% CI, 1.14–1.28) per standardized unit of genetically predicted BMI.
Conclusions: Asian women experience a high, heterogeneous, and escalating OA burden with a significant peak occurring in the 50–59 age group. High BMI is a potentially modifiable causal risk factor. Region- and sex-specific prevention strategies focused on weight management and joint health for the 50–59 age group are urgently required to mitigate projected incidence by 2050.
Related
- Group A Streptococcus-Attributable Mortality and Disability in Asian Adults Aged 60 Years and Older: Global Burden of Disease Study 2023 and Projections to 2050
- Tobacco-attributable burden of alzheimer’s disease and other dementias in China and ASEAN : Temporal trends and projections – an observational study based on GBD 2021
- Diet-attributable colorectal cancer in Asia: Regional heterogeneity in burden and dietary intake
- Early-onset digestive system cancers attributable to the GBD composite dietary risk in China, 1990-2023: burden, trends, and projections.
- Epidemiological trends, projections, and attributable risk factors of esophageal cancer: a comparative study of four Western Pacific countries, 1990–2040
BibTeX
@article{zhang2026escalating,
title = {{Escalating Burden of Osteoarthritis Among Asian Women: Regional Trends, BMI-Attributable Disability, and Projections to 2050}},
author = {Wenjing Zhang and Haoran Peng and Li Li and Wei Liu},
journal = {International Journal of Women's Health},
year = {2026},
month = oct,
doi = {10.2147/ijwh.s631049},
url = {https://doi.org/10.2147/ijwh.s631049},
note = {CC BY-NC 4.0},
}
RIS
TY - JOUR
TI - Escalating Burden of Osteoarthritis Among Asian Women: Regional Trends, BMI-Attributable Disability, and Projections to 2050
AU - Wenjing Zhang
AU - Haoran Peng
AU - Li Li
AU - Wei Liu
PY - 2026
DA - 2026/10/27
JO - International Journal of Women's Health
DO - 10.2147/ijwh.s631049
UR - https://doi.org/10.2147/ijwh.s631049
AB - Background: Osteoarthritis (OA) imposes a substantial and growing burden on women in Asia, yet comprehensive sex-specific and subregional analyses that incorporate causal inference and long-term forecasting remain limited. Objective: This study quantified the burden of OA among Asian women from 1990 to 2023, characterized spatiotemporal patterns, projected trends to 2050, and evaluated the causal role of high body mass index (BMI). Methods: Using Global Burden of Disease 2023 data, we extracted age-standardized incidence (ASIR), prevalence, and disability-adjusted life-year rates for women across Asian regions and countries. Temporal trends were assessed with estimated annual percentage change and joinpoint regression. Future burden was forecasted using Bayesian age-period-cohort (BAPC) models and exponential smoothing (ETS) models. The proportion of OA disability attributable to high BMI was calculated. Two-sample Mendelian randomization (MR) used sex-combined East Asian BMI and mixed-ancestry OA genome-wide association study (GWAS) data. Results: In 2023, female ASIR was highest in East Asia (658.85 per 100,000) and Central Asia (613.07 per 100,000), while other Asian subregions were below the global female ASIR. Age-specific incidence peaked at 50–59 age group across all sub-regions. Asian regions showed faster long-term increases than the global average, although most exhibited deceleration after 2020. Projections indicate that by 2050, the ASIR of OA in females will decline across all regions. The high BMI attributable fraction of OA disability rose markedly, reaching 29.0% in Western Asia. The reported multiplicative random-effects inverse-variance-weighted (IVW) MR estimate was an odds ratio (OR) of 1.21 (95% CI, 1.14–1.28) per standardized unit of genetically predicted BMI. Conclusions: Asian women experience a high, heterogeneous, and escalating OA burden with a significant peak occurring in the 50–59 age group. High BMI is a potentially modifiable causal risk factor. Region- and sex-specific prevention strategies focused on weight management and joint health for the 50–59 age group are urgently required to mitigate projected incidence by 2050.
SN - 1179-1411
ER -